Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 2/2014

Ausgabe 2/2014

Inhaltsverzeichnis ( 10 Artikel )

01.02.2014 | Review | Ausgabe 2/2014

Neuropilin 1: function and therapeutic potential in cancer

Belal Chaudhary, Yazan S. Khaled, Basil J. Ammori, Eyad Elkord

01.02.2014 | Original Article | Ausgabe 2/2014

HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers

Mary L. Disis, Yushe Dang, Andrew L. Coveler, Edmond Marzbani, Zhong C. Kou, Jennifer S. Childs, Patricia Fintak, Doreen M. Higgins, Jessica Reichow, James Waisman, Lupe G. Salazar

01.02.2014 | Original Article | Ausgabe 2/2014

Critical role of spatial interaction between CD8+ and Foxp3+ cells in human gastric cancer: the distance matters

Anita Feichtenbeiner, Matthias Haas, Maike Büttner, Gerhard G. Grabenbauer, Rainer Fietkau, Luitpold V. Distel

01.02.2014 | Original Article | Ausgabe 2/2014

An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression

Pengfei Zhang, Bizhi Shi, Huiping Gao, Hua Jiang, Juan Kong, Jin Yan, Xiaorong Pan, Kesang Li, Pengwei Zhang, Ming Yao, Shengli Yang, Jianren Gu, Hongyang Wang, Zonghai Li

01.02.2014 | Original Article | Ausgabe 2/2014

Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial

Ryan D. Guest, Natalia Kirillova, Sam Mowbray, Hannah Gornall, Dominic G. Rothwell, Eleanor J. Cheadle, Eric Austin, Keith Smith, Suzanne M. Watt, Klaus Kühlcke, Nigel Westwood, Fiona Thistlethwaite, Robert E. Hawkins, David E. Gilham

01.02.2014 | Original Article | Ausgabe 2/2014

The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study

Peggy J. de Vos van Steenwijk, Mariette I. E. van Poelgeest, Tamara H. Ramwadhdoebe, Margriet J. G. Löwik, Dorien M. A. Berends-van der Meer, Caroline E. van der Minne, Nikki M. Loof, Linda F. M. Stynenbosch, Lorraine M. Fathers, A. Rob P. M. Valentijn, Jaap Oostendorp, Elisabeth M. Osse, Gert Jan Fleuren, Linda Nooij, Marjolein J. Kagie, Bart W. J. Hellebrekers, Cornelis J. M. Melief, Marij J. P. Welters, Sjoerd H. van der Burg, Gemma G. Kenter

01.02.2014 | Original Article | Ausgabe 2/2014

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

Caroline Jochems, Jo A. Tucker, Matteo Vergati, Benjamin Boyerinas, James L. Gulley, Jeffrey Schlom, Kwong-Yok Tsang

01.02.2014 | Original Article | Ausgabe 2/2014

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer

Nicola E. Annels, Victoria E. Shaw, Rachel F. Gabitass, Lucinda Billingham, Pippa Corrie, Martin Eatock, Juan Valle, David Smith, Jonathan Wadsley, David Cunningham, Hardev Pandha, John P. Neoptolemos, Gary Middleton

01.02.2014 | Meeting Report | Ausgabe 2/2014

Advances in cellular therapy: 7th international symposium on the clinical use of cellular products, March 14 and 15, 2013, Erlangen, Germany

Michael Aigner, Heiko Bruns, Regina Gary, Regina Jitschin, Anita Kremer, Dimitrios Mougiakakos, Simon Völkl, Andreas Mackensen, Armin Gerbitz

01.02.2014 | ACKNOWLEDGEMENT TO REVIEWERS | Ausgabe 2/2014

Acknowledgement

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise